Evaluation of Saliva Melatonin Levels in Head-neck Radiotherapy Patients

Year 2022, Volume: 23 Issue: 3, 291 - 295, 30.09.2022

Gözde Açıkgöz , Nilgün Akgül

Abstract

Objective: Melatonin (MT), which performs many missions such as the activation of the immune system, regulation of the body’s circadian rhythm and body temperature, is a powerful antioxidant. This study investigated the impact of radiation on the saliva MT level in individuals with head and neck cancer.
Materials and Methods: Sixteen patients receiving head and neck radiotherapy were included in the study. The MT levels were measured in salivary samples taken from these patients before and after radiotherapy and in salivary samples taken from thirty healthy individuals who had no radiotherapy. Paired t-test and Student’s t-test were used in the analysis of the data obtained.
Results: When the saliva MT levels were compared before and after radiotherapy in the patient group, although there was a decrease after radiotherapy, there was not found a statistically significant difference (p>0.05). Additionally, although the saliva MT levels before and after radiotherapy were determined to be lower than the control group, there was no significant (p>0.05).
Conclusion: Although there was no significant difference, the important decrease in saliva MT levels after radiotherapy in the patient group will enable us to understand more clearly the effect of ionizing radiation on saliva MT level.

Keywords

Head and neck cancer , melatonin , radiotherapy , saliva

References

• 1. Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 2006; 107: 2525-34.
• 2. Imanimoghaddam M, Rahrooh M, Tafakhori Z, Zahedanaraki S, Homaeieshandiz F. Changes of parotid and submandibular glands caused by radiotherapy--an ultrasound evaluation. Dentomaxillofac Radiol 2012; 41: 379-84.
• 3. Ahadian H, Yassaei S, Bouzarjomehri F, Targhi MG, Kheirollahi K. Oral Complications of The Oromaxillofacial Area Radiotherapy. Asian Pac J Cancer Prev 2017; 18: 721-5.
• 4. Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent 2009; 3: 100-6.
• 5. Khalil Arjmandi M, Moslemi D, Sadati Zarrini A, Ebrahimnezhad Gorji M, Mosapour A, Haghhaghighi A, et al. Pre and post radiotherapy serum oxidant/antioxidant status in breast cancer patients: Impact of age, BMI and clinical stage of the disease. Rep Pract Oncol Radiother 2016; 21: 141-8.
• 6. Nguyen TT, Ngo LQ, Promsudthi A, Surarit Rl. Salivary Lipid Peroxidation in Patients With Generalized Chronic Periodontitis and Acute Coronary Syndrome. J Periodontol 2016; 87: 134-41.
• 7. Shariff AK, Patil SR, Shukla PS, Sontakke AV, Hendre AS, Gudur AK. Effect of oral antioxidant supplementation on lipid peroxidation during radiotherapy in head and neck malignancies. Indian J Clin Biochem 2009; 24: 307-11.
• 8. Demirci S, Ozsaran Z, Celik HA, Aras AB, Aydin HH. The interaction between antioxidant status and cervical cancer: a case control study. Tumori 2011; 97: 290-5.
• 9. Gupta S, Singh KK, Vyas VJ, Chaturvedi VN, Reddy MV, Harinath BC. Assessment of oxidative stress and effect of antioxidant supplementation during radiotherapy in carcinoma of upper digestive tract. Indian J Clin Biochem 2000; 15: 52-5.
• 10. Khademi H, Khozeimeh F, Tavangar A, Amini S, Ghalayani P. The Serum and salivary level of malondialdehyde, vitamins A, E, and C in patient with recurrent aphthous stomatitis. Adv Biomed Res 2014; 3: 246.
• 11. Ziaudeen S, Ravindran R. Assessment of Oxidant-Antioxidant Status and Stress Factor in Recurrent Aphthous Stomatitis Patients: Case Control Study. J Clin Diagn Res 2017; 11: ZC01-4.
• 12. Abdolsamadi H, Goodarzi MT, Ahmadi Motemayel F, Jazaeri M, Feradmal J, Zarabadi M, et al. Reduction of Melatonin Level in Patients with Type II Diabetes and Periodontal Diseases. J Dent Res Dent Clin Dent Prospects 2014; 8: 160-5.
• 13. Lodhi K, Saimbi CS, Khan MA, Nath C, Shukla R. Evaluation of melatonin levels in saliva in gingivitis and periodontitis cases: A pilot study. Contemp Clin Dent 2016; 7: 519-23.
• 14. Laakso ML, Porkka-Heiskanen T, Alila A, Stenberg D, Johansson G. Correlation between salivary and serum melatonin: dependence on serum melatonin levels. J Pineal Res 1990; 9: 39-50.
• 15. Büyükköprü D, Dural S. The Investigation of Influence of Head and Neck Radiotherapy on Flow Rate and Ph of Saliva. Clinical Dentistry and Research 2008; 32: 71-8.
• 16. Lin CY, Ju SS, Chia JS, Chang CH, Chang CW, Chen MH. Effects of radiotherapy on salivary gland function in patients with head and neck cancers. J Dental Sci 2015; 10: 253-62.
• 17. Cakmak Karaer I, Simsek G, Yildiz A, Vardi N, Polat A, Tanbek K, et al. Melatonin's protective effect on the salivary gland against ionized radiation damage in rats. J Oral Pathol Med 2016; 45: 444-9.
• 18. Babiuch K, Bednarczyk A, Gawlik K, Pawlica-Gosiewska D, Kesek B, Darczuk D, et al. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study. Acta Odontol Scand 2019; 77: 408-18.
• 19. Balaji TM, Vasanthi HR, Rao SR. Gingival, plasma and salivary levels of melatonin in periodontally healthy individuals and chronic periodontitis patients: a pilot study. J Clin Diagn Res 2015; 9: ZC23-5.
• 20. Gómez-Moreno G, Cutando-Soriano A, Arana C, Galindo P, Bolaños J, Acuña-Castroviejo D, et al. Melatonin expression in periodontal disease. J Periodontal Res 2007; 42: 536-40.
• 21. Cevik-Aras H, Godoy T, Ekstrom J. Melatonin-induced protein synthesis in the rat parotid gland. J Physiol Pharmacol 2011; 62: 95-9.
• 22. Martins RA, Cunha MR, Neves AP, Martins M, Teixeira-Verissimo M, Teixeira AM. Effects of aerobic conditioning on salivary IgA and plasma IgA, IgG and IgM in older men and women. Int J Sports Med 2009; 30: 906-12.
• 23. Messner M, Hardeland R, Rodenbeck A, Huether G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998; 25: 251-9.
• 24. Agha-Hosseini F, Mirzaii-Dizgah I, Farmanbar N, Abdollahi M. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. J Oral Pathol Med 2012; 41: 736-40.
• 25. Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol 2018; 217: 2291-8.